https://www.selleckchem.com/pr....oducts/heptadecanoic
Amlodipine was associated with lower stroke risk in patients with Alzheimer's dementia compared to other CCBs (aHR 0.63; CI, 0.44-0.89; P0.05). Sensitivity analyses with propensity score-matched cohorts repeated the results for nifedipine (aHR 1.35; 95% CI, 1.02-1.78; P0.05) and amlodipine in AD (aHR, 0.87; CI, 0.78-0.97; P0.05) and DLB-PDD (aHR, 0.56, 95%CI, 0.37-0.85; P0.05). Amlodipine was associated with reduced mortality risk in dementia patients diagnosed with AD and DLB-PDD. AD patients using amlodipine
Like
Comment
Share
